Fisher Asset Management Portfolio holdings
Fisher Asset Management, LLC, operating as Fisher Investments, was founded in 1979 by Ken Fisher and is headquartered in Plano, Texas, following a relocation from Camas, Washington, in 2023. As an independent, fee-only investment adviser, it manages over $275 billion in assets for individual and institutional investors globally as of June 2024, offering tailored portfolio management through its Private Client Group and Institutional Group. Known for its active, top-down investment approach guided by a five-member Investment Policy Committee, the firm emphasizes asset allocation and has expanded internationally with offices in eight countries, including a wholly owned subsidiary, Fisher Investments Europe Limited, in London. With Ken Fisher as executive chairman and co-chief investment officer, succeeded as CEO by Damian Ornani in 2016, Fisher Investments blends a legacy of innovation with a client-first philosophy, recently spinning off its 401(k) Solutions into Fisher Retirement Solutions in 2024.
Top Buys
| 1 |
TotalEnergies
TTE
|
$1.01B |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
$353M |
| 3 |
BP
BP
|
$301M |
| 4 |
Rio Tinto
RIO
|
$264M |
| 5 |
Vale
VALE
|
$264M |
Top Sells
| 1 |
Berkshire Hathaway Class B
BRK.B
|
$638M |
| 2 |
BAY
BAYER AG SPONS ADR
BAY
|
$441M |
| 3 |
Johnson & Johnson
JNJ
|
$257M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
$189M |
| 5 |
Vodafone
VOD
|
$153M |
Sector Composition
| 1 | Technology | 16.26% |
| 2 | Financials | 13.72% |
| 3 | Healthcare | 11.39% |
| 4 | Consumer Discretionary | 8.65% |
| 5 | Energy | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Oracle
ORCL
$635B
| $728M | 0.88% | 14,122,584 +484,391 | +4% | +$25M |
|
|
FFEU
27
DELISTED
Barclays ETN+ FI Enhanced Europe 50 ETN Series C
FFEU
| $728M | 0.88% | 7,622,604 +556,212 | +8% | +$53.1M |
|
|
SI
28
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
| $714M | 0.87% | 11,136,250 +375,592 | +3% | +$24.1M |
|
29
Sanofi
SNY
$121B
| $698M | 0.85% | 15,626,683 +4,121 | +0% | +$184K |
|
30
HSBC
HSBC
$224B
| $692M | 0.84% | 15,726,602 +463,230 | +3% | +$20.4M |
|
31
Novo Nordisk
NVO
$251B
| $650M | 0.79% | 13,797,404 +227,733 | +2% | +$10.7M |
|
32
Novartis
NVS
$245B
| $640M | 0.78% | 7,425,077 +99,816 | +1% | +$8.6M |
|
33
Costco
COST
$418B
| $630M | 0.76% | 2,680,719 +82,875 | +3% | +$19.5M |
|
34
JPMorgan Chase
JPM
$829B
| $589M | 0.71% | 5,218,198 +8,350 | +0.2% | +$942K |
|
35
RTX Corp
RTX
$212B
| $586M | 0.71% | 4,194,261 +107,596 | +3% | +$15M |
|
36
Merck
MRK
$210B
| $571M | 0.69% | 8,046,143 +117,937 | +1% | +$8.37M |
|
37
ING
ING
$70.3B
| $570M | 0.69% | 43,945,914 +649,044 | +1% | +$8.42M |
|
38
AB InBev
BUD
$122B
| $565M | 0.69% | 6,446,579 +100,075 | +2% | +$8.76M |
|
39
Chevron
CVX
$324B
| $564M | 0.68% | 4,612,686 +218,456 | +5% | +$26.7M |
|
40
GSK
GSK
$79.9B
| $563M | 0.68% | 14,011,328 +187,205 | +1% | +$7.52M |
|
41
AstraZeneca
AZN
$248B
| $535M | 0.65% | 13,516,724 +436,783 | +3% | +$17.3M |
|
42
iShares MBS ETF
MBB
$41B
| $512M | 0.62% | 4,957,367 -442,573 | -8% | -$45.7M |
|
|
FIEE
43
DELISTED
FI Enhanced Europe 50 ETN
FIEE
| $510M | 0.62% | 3,182,589 -45,472 | -1% | -$7.29M |
|
|
RDS.A
44
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $510M | 0.62% | 7,477,967 +1,933,865 | +35% | +$132M |
|
|
45
Vale
VALE
$43.9B
| $506M | 0.61% | 34,121,206 +17,769,298 | +109% | +$264M |
|
46
Exxon Mobil
XOM
$487B
| $498M | 0.6% | 5,855,133 +228,513 | +4% | +$19.4M |
|
47
Petrobras
PBR
$79.9B
| $490M | 0.59% | 40,588,956 +7,359,485 | +22% | +$88.8M |
|
48
Sumitomo Mitsui Financial
SMFG
$105B
| $477M | 0.58% | 59,436,375 +1,647,316 | +3% | +$13.2M |
|
49
Banco Santander
SAN
$141B
| $475M | 0.58% | 94,934,126 +1,827,838 | +2% | +$9.14M |
|
|
50
Rio Tinto
RIO
$102B
| $473M | 0.57% | 9,275,526 +5,169,326 | +126% | +$264M |
|